FDA Patient Listening Session

PFS Network was pleased to be granted a Patient Listening Session with the FDA recently.

In this session, our charity provided an overview of the disease, the clinical reality facing patients, and current research underway. Six different patients then provided testimonials about their experience with Post-Finasteride Syndrome to a panel of approximately 30 FDA staff.

You can find an overview of the session here.